Laprophan targets up to 2.2 billion dirhams in stock market listing
By the AFREEQUE newsroom, based on TelQuel
Moroccan pharmaceutical company Laprophan is launching a public subscription ahead of its stock market listing, with a potential value of up to 2.2 billion dirhams. The Moroccan Capital Market Authority has approved the operation, according to TelQuel.
Laprophan, a Moroccan pharmaceutical laboratory founded in Casablanca in 1949, is seeking to raise up to 2.2 billion dirhams through its listing on the Casablanca Stock Exchange. The Moroccan Capital Market Authority (AMMC) approved the operation on 28 October, TelQuel reports.
The public subscription is due to open in less than two weeks, according to TelQuel. The operation comes as the MASI, the Casablanca Stock Exchange’s main index, closed below 17,000 points on 26 October, after falling 0.32% (the MASI’s decline).
